BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31963760)

  • 1. Multiple Cell Signalling Pathways of Human Proinsulin C-Peptide in Vasculopathy Protection.
    Souto SB; Campos JR; Fangueiro JF; Silva AM; Cicero N; Lucarini M; Durazzo A; Santini A; Souto EB
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-peptide replacement therapy as an emerging strategy for preventing diabetic vasculopathy.
    Bhatt MP; Lim YC; Ha KS
    Cardiovasc Res; 2014 Nov; 104(2):234-44. PubMed ID: 25239825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats.
    Kamikawa A; Ishii T; Shimada K; Makondo K; Inanami O; Sakane N; Yoshida T; Saito M; Kimura K
    Diabetes Metab Res Rev; 2008; 24(4):331-8. PubMed ID: 18088079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-peptide antioxidant adaptive pathways in β cells and diabetes.
    Luppi P; Drain P
    J Intern Med; 2017 Jan; 281(1):7-24. PubMed ID: 27251308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proinsulin C-peptide -- the bioactive peptide with a huge promise].
    Walenciak Ł; Fendler W; Młynarski W
    Pediatr Endocrinol Diabetes Metab; 2007; 13(2):95-8. PubMed ID: 17880815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinsulin C-peptide prevents impaired wound healing by activating angiogenesis in diabetes.
    Lim YC; Bhatt MP; Kwon MH; Park D; Na S; Kim YM; Ha KS
    J Invest Dermatol; 2015 Jan; 135(1):269-278. PubMed ID: 25007043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of C-peptide on experimentally induced diabetic nephropathy and the possible link between C-peptide and nitric oxide.
    Elbassuoni EA; Aziz NM; El-Tahawy NF
    Appl Physiol Nutr Metab; 2018 Jun; 43(6):617-624. PubMed ID: 29351386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-peptide as a therapeutic tool in diabetic nephropathy.
    Hills CE; Brunskill NJ; Squires PE
    Am J Nephrol; 2010; 31(5):389-97. PubMed ID: 20357430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular mechanisms of action and physiological effects of the proinsulin C-peptide (a systematic review)].
    Poteryaeva ON; Usynin IF
    Biomed Khim; 2020 May; 66(3):196-207. PubMed ID: 32588825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of C-peptide on diabetic nephropathy: A review of molecular mechanisms.
    Yaribeygi H; Maleki M; Sathyapalan T; Sahebkar A
    Life Sci; 2019 Nov; 237():116950. PubMed ID: 31605709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinsulin C-peptide: friend or foe in the development of diabetes-associated complications?
    Nordquist L; Johansson M
    Vasc Health Risk Manag; 2008; 4(6):1283-8. PubMed ID: 19337542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-peptide: new findings and therapeutic implications in diabetes.
    Wahren J
    Clin Physiol Funct Imaging; 2004 Jul; 24(4):180-9. PubMed ID: 15233831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and physiological effects of C-peptide.
    Hills CE; Brunskill NJ
    Clin Sci (Lond); 2009 Apr; 116(7):565-74. PubMed ID: 19243312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-peptide, Na+,K(+)-ATPase, and diabetes.
    Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
    Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein.
    Mughal RS; Scragg JL; Lister P; Warburton P; Riches K; O'Regan DJ; Ball SG; Turner NA; Porter KE
    Diabetologia; 2010 Aug; 53(8):1761-71. PubMed ID: 20461358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-peptide activates AMPKα and prevents ROS-mediated mitochondrial fission and endothelial apoptosis in diabetes.
    Bhatt MP; Lim YC; Kim YM; Ha KS
    Diabetes; 2013 Nov; 62(11):3851-62. PubMed ID: 23884890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of VEGF-mediated microvascular permeability by C-peptide in diabetic mice.
    Lim YC; Bhatt MP; Kwon MH; Park D; Lee S; Choe J; Hwang J; Kim YM; Ha KS
    Cardiovasc Res; 2014 Jan; 101(1):155-64. PubMed ID: 24142430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells.
    Al-Rasheed NM; Meakin F; Royal EL; Lewington AJ; Brown J; Willars GB; Brunskill NJ
    Diabetologia; 2004 Jun; 47(6):987-97. PubMed ID: 15164168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of proinsulin C-peptide in experimental diabetic neuropathy: vascular actions and modulation by nitric oxide synthase inhibition.
    Cotter MA; Ekberg K; Wahren J; Cameron NE
    Diabetes; 2003 Jul; 52(7):1812-7. PubMed ID: 12829651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proinsulin C-peptide prevents hyperglycemia-induced vascular leakage and metastasis of melanoma cells in the lungs of diabetic mice.
    Jeon HY; Lee YJ; Kim YS; Kim SY; Han ET; Park WS; Hong SH; Kim YM; Ha KS
    FASEB J; 2019 Jan; 33(1):750-762. PubMed ID: 30020832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.